UNCY 财务： Unicycive Therapeutics Inc AI 分析

Q: 技术分析指标如何适用于 UNCY？

根据技术分析，Unicycive Therapeutics Inc 的综合信号为 Buy。Unicycive Therapeutics Inc 有 5 个买入信号，0 个中性信号和 2 个卖出信号。

Q: UNCY 的斐波那契回调水平是多少？

Unicycive Therapeutics Inc 的斐波那契回调水平是 高于0%水平。

Q: Unicycive Therapeutics Inc 的 RSI 是多少？

Unicycive Therapeutics Inc 的 RSI 目前为 73.83，表明处于 超买 状态

Q: Unicycive Therapeutics Inc 接下来 12 个月的价格是多少？

Unicycive Therapeutics Inc UNCY 接下来 12 个月的价格预计为 $47.43。

Q: Unicycive Therapeutics Inc 预计会涨到多高？

据华尔街分析师称，Unicycive Therapeutics Inc 预计将达到 $94.5 的高预测值。

主页

股票

UNCY

预测

UNCY 股票价格预测

Unicycive Therapeutics Inc

$6.92

-2.94%

$-0.2

收盘价：Jan 23, 16:00:00 GMT-5

$6.94

0.43%

$0.02

盘后：Jan 23, 20:00:00 GMT-5

概述预测收益股息财务数据

关键数据

前收盘价

$7.13

开盘价

$7.13

当日区间

$6.87 - $7.13

52周范围

$3.71 - $11

交易量

480.8K

平均成交量

447.1K

每股收益（TTM）

-2.01

股息收益率

市值

$149.3M

什么是 UNCY？

Unicycive Therapeutics, Inc. engages in the development of treatment for kidney diseases. The company is headquartered in Los Altos, California and currently employs 22 full-time employees. The company went IPO on 2021-06-17. The firm's lead drug candidate, oxylanthanum carbonate (OLC), is an investigational phosphate binding agent being developed for the treatment of hyperphosphatemia in chronic kidney disease patients on dialysis. Its second asset, UNI-494, is a patent-protected new chemical entity in clinical development for the treatment of conditions related to acute kidney injury.

功能特性

交易策略

资源

市场

Utilizing our sophisticated predictive model, we anticipate notable price fluctuations for UNCY in the upcoming periods. Looking toward the future, our 2027 projection indicates an average price target of $47.43. The lowest target is $21.21 and the highest is $94.5. Empower your investment choices with our cutting-edge, data-driven analysis!

UNCY 股价预测摘要

UNCY的顶级分析师评级

基于 14 位分析师对 UNCY 的股票评级，更新于 Nov 01, 2025

Buy

Strong buy

Buy

Hold

Sell

Strong sell

Leveraging in-depth analyst evaluations, we have synthesized key insights from expert assessments to present a positive outlook for UNCY. Analysts highlight solid fundamentals and favorable market sentiment, suggesting upside potential in the near term. Based on this thorough expert analysis, we maintain an optimistic view of this stock. Our conclusion: UNCY is a Buy candidate.

UNCY stock price ended at $7.13 on 星期四, after rising 8.03%

On the latest trading day Jan 22, 2026, the stock price of UNCY rose by 8.03%, climbing from $6.65 to $7.13. During the session, the stock saw a volatility of 9.44%, with prices oscillating between a daily low of $6.57 and a high of $7.19. Notably, trading volume dropped by 401.6K shares on the last day despite the price increase, which may signal a potential uptick in risk in the near term. A total of 827.6K shares were traded, equating to a market value of approximately $153.2M.

UNCY 技术面信号

技术面信号摘要

购买信号 5

中性信号 0

卖出信号 2

Strong Sell

Sell

Neutral

Buy

Strong Buy

UNCY目前显示5个买入信号和2个卖出信号。该股票自12:00 AM以来一直处于上升趋势状态，在此期间价格总变动为15.19%。总体而言，技术指标显示中期前景为Buy。

UNCY 的看涨/看跌信号

我们的算法通过分析移动平均线、RSI、MACD 和成交量等关键指标，为 UNCY 生成看涨和看跌信号。这些见解可助您做出明智的投资决策。

后续问题

技术分析指标如何适用于 UNCY？



UNCY 的斐波那契回调水平是多少？



Unicycive Therapeutics Inc 的 RSI 是多少？



Unicycive Therapeutics Inc 接下来 12 个月的价格是多少？



Unicycive Therapeutics Inc 预计会涨到多高？



Unicycive Therapeutics Inc（UNCY）价格

UNCY 股价走势图